Literature DB >> 35121593

Covid-19: UK approves Novavax's protein based vaccine.

Jacqui Wise1.   

Abstract

Entities:  

Year:  2022        PMID： 35121593     DOI： 10.1136/bmj.o309

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants.

Authors:  Dinah V Parums
Journal:  Med Sci Monit       Date:  2022-03-01

Review 2.  Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases.

Authors:  Jing-Xing Yang; Jen-Chih Tseng; Guann-Yi Yu; Yunping Luo; Chi-Ying F Huang; Yi-Ren Hong; Tsung-Hsien Chuang
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.525
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.